According to Vasta Platform's latest financial reports and stock price the company's current Operating Margin is 12.86%. At the end of 2021 the company had an Operating Margin of -16.45%.
Year | Operating Margin | Change |
---|---|---|
2021 | -16.45% | 130.96% |
2020 | -7.12% | -21.95% |
2019 | -9.13% |
Company | Operating Margin | Operating Margin differencediff. | Country |
---|---|---|---|
Verastem Oncology
VSTM | -2,007.43% | -15,709.88% | ๐บ๐ธ USA |
Spectrum Pharmaceuticals
SPPI | -109.76% | -953.50% | ๐บ๐ธ USA |
Emergent BioSolutions
EBS | 17.53% | 36.31% | ๐บ๐ธ USA |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.